POM
Income statement / Annual
Last year (2025), Pomdoctor Ltd.'s total revenue was $399.91 M,
an increase of 16.74% from the previous year.
In 2025, Pomdoctor Ltd.'s net income was -$212.58 M.
See Pomdoctor Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$399.91 M |
$342.56 M |
$304.85 M |
$245.22 M |
$215.38 M |
| Cost of Revenue |
$347.63 M
|
$294.86 M
|
$266.13 M
|
$190.36 M
|
$162.88 M
|
| Gross Profit |
$52.28 M
|
$47.69 M
|
$38.72 M
|
$54.86 M
|
$52.51 M
|
| Gross Profit Ratio |
0.13
|
0.14
|
0.13
|
0.22
|
0.24
|
| Research and Development Expenses |
$12.86 M
|
$3.00 M
|
$3.37 M
|
$3.59 M
|
$4.28 M
|
| General & Administrative Expenses |
$59.73 M
|
$11.88 M
|
$12.31 M
|
$7.41 M
|
$18.85 M
|
| Selling & Marketing Expenses |
$96.21 M
|
$56.37 M
|
$43.68 M
|
$47.46 M
|
$84.10 M
|
| Selling, General & Administrative Expenses |
$155.94 M
|
$68.24 M
|
$55.99 M
|
$54.87 M
|
$102.95 M
|
| Other Expenses |
-$152.60 K
|
$2.24 M
|
$1.61 M
|
$0.00
|
$24.94 M
|
| Operating Expenses |
$168.66 M
|
$73.49 M
|
$60.97 M
|
$58.46 M
|
$132.18 M
|
| Cost And Expenses |
$516.29 M
|
$368.35 M
|
$327.10 M
|
$248.81 M
|
$295.05 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$12.89 M
|
$12.96 M
|
$13.85 M
|
$16.02 M
|
$16.29 M
|
| Depreciation & Amortization |
$149.31 K
|
$134.51 K
|
$112.09 K
|
$0.00
|
$21.32 M
|
| EBITDA |
-$117.90 M |
-$24.27 M |
-$22.99 M |
-$3.81 M |
-$58.58 M |
| EBITDA Ratio |
-0.29
|
-0.07
|
-0.08
|
-0.02
|
-0.27
|
| Operating Income Ratio |
-0.29
|
-0.08
|
-0.07
|
-0.01
|
-0.37
|
| Total Other Income/Expenses Net |
-$14.56 M
|
-$11.57 M
|
-$14.70 M
|
-$16.24 M
|
-$16.51 M
|
| Income Before Tax |
-$130.93 M
|
-$37.37 M
|
-$36.95 M
|
-$19.83 M
|
-$96.18 M
|
| Income Before Tax Ratio |
-0.33
|
-0.11
|
-0.12
|
-0.08
|
-0.45
|
| Income Tax Expense |
$375.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$212.58 M
|
-$143.36 M
|
-$145.39 M
|
-$125.51 M
|
-$188.40 M
|
| Net Income Ratio |
-0.53
|
-0.42
|
-0.48
|
-0.51
|
-0.87
|
| EPS |
-3.66 |
-21.78 |
-22.14 |
-19.08 |
-28.62 |
| EPS Diluted |
-3.66 |
-21.78 |
-22.14 |
-19.08 |
-28.62 |
| Weighted Average Shares Out |
$58.08 M
|
$6.58 M
|
$6.58 M
|
$6.58 M
|
$6.58 M
|
| Weighted Average Shares Out Diluted |
$58.08 M
|
$6.58 M
|
$6.58 M
|
$6.58 M
|
$6.58 M
|
| Link |
|
|
|
|
|
